A novel flow cytometry based assay for quantification of corneal angiogenesis in the mouse model of herpetic stromal keratitis

Experimental Eye Research

Volumn 80, Issue 1, 2005, Pages 73-81

  Biswas, Partha S ^a   Banerjee, Kaustuv ^a   Kim, Bumseok ^a   Smith, Jordan ^b   Rouse, Barry T ^a,c  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c Natural Resources   (United States)

Author keywords

angiogenesis; CD31; cornea; flow cytometry; herpes simplex virus; herpetic stromal keratitis

Indexed keywords

ANTIBODY; CD31 ANTIBODY; CD31 ANTIGEN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; ASSAY; BLOOD VESSEL; CELL COUNT; CELL ISOLATION; CONTROLLED STUDY; CORNEA; DEVELOPMENT; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; FROZEN SECTION; HERPES; HERPES SIMPLEX VIRUS 1; HERPETIC STROMAL KERATITIS; KERATITIS; MEASUREMENT; MICROSCOPE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SLIT LAMP; STAINING;

ANIMALS; ANTIGENS, CD31; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; KERATITIS, HERPETIC; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; SIMPLEXVIRUS; STROMAL CELLS; VIRAL LOAD;

EID: 12344281810     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2004.08.014     Document Type: Article

References (12)

1. B.K. Ambati, A. Anand, A.M. Joussen, W.A. Kuziel, A.P. Adamis, and J. Ambati Sustained inhibition of corneal neovascularization by genetic ablation of CCR5 Invest. Ophthalmol. Vis. Sci. 44 2003 590 593
2. M.R. Dana, S.N. Zhu, and J. Yamada Topical modulation of interleukin-1 activity in corneal neovascularization Cornea 17 1998 403 409
3. S. Deshpande, M. Zheng, S. Lee, K. Banerjee, S. Gangappa, U. Kumaraguru, and B.T. Rouse Bystander activation involving T lymphocytes in herpetic stromal keratitis J. Immunol. 167 2001 2902 2910
4. S. Deshpande, K. Banerjee, P.S. Biswas, and B.T. Rouse Herpetic eye disease: immunopathogenesis and therapeutic measures Expert Rev. Mol. Med. 30 2004 1 14
5. R. Hoffman Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models Lancet Oncol. 3 2002 546 556
6. M. Hristov, W. Erl, and P.C. Weber Endothelial progenitor cells: mobilization, differentiation, and homing Arterioscler. Thromb. Vasc. Biol. 23 2003 1185 1189
7. J.S. Pober Effects of tumour necrosis factor and related cytokines on vascular endothelial cells Ciba Found Symp. 131 1987 170 184
8. P.G. Spear, and B. Roizman Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpes virion J. Virol. 9 1972 143 159
9. J.W. Streilein, M.R. Dana, and B.R. Ksander Immunity causing blindness: five different paths to herpes stromal keratitis Immunol. Today 18 1997 443 449
10. D. Strohmeyer, F. Frauscher, A. Klauser, W. Recheis, G. Eibl, W. Horninger, H. Steiner, H. Volgger, and G. Bartsch Contrast-enhanced transrectal color doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer Anticancer Res. 21 2001 2907 2913
11. W. Vorkauf, M. Vorkauf, B. Nolle, and G. Duncker Adhesion molecules in normal and pathological corneas. An immunohistochemical study using monoclonal antibodies Graefes Arch. Clin. Exp. Ophthalmol. 233 1995 209 219
12. M. Zheng, S. Deshpande, S. Lee, N. Ferrara, and B.T. Rouse Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis J. Virol. 75 2001 9828 9835